175 related articles for article (PubMed ID: 7735588)
1. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1.
Rijcken B; Schouten JP; Xu X; Rosner B; Weiss ST
Am J Respir Crit Care Med; 1995 May; 151(5):1377-82. PubMed ID: 7735588
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with bronchial responsiveness to histamine in a population sample of adults.
Rijcken B; Schouten JP; Mensinga TT; Weiss ST; De Vries K; Van der Lende R
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1447-53. PubMed ID: 8503555
[TBL] [Abstract][Full Text] [Related]
3. The relationship between airway responsiveness to histamine and pulmonary function level in a random population sample.
Rijcken B; Schouten JP; Weiss ST; Speizer FE; van der Lende R
Am Rev Respir Dis; 1988 Apr; 137(4):826-32. PubMed ID: 3354988
[TBL] [Abstract][Full Text] [Related]
4. Bronchial responsiveness and five-year FEV1 decline: a study in miners and nonminers.
Hodgins P; Henneberger PK; Wang ML; Petsonk EL
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1390-6. PubMed ID: 9603113
[TBL] [Abstract][Full Text] [Related]
5. The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample.
Rijcken B; Schouten JP; Weiss ST; Speizer FE; van der Lende R
Am Rev Respir Dis; 1987 Jul; 136(1):62-8. PubMed ID: 3605843
[TBL] [Abstract][Full Text] [Related]
6. Perception of airway obstruction in a random population sample. Relationship to airway hyperresponsiveness in the absence of respiratory symptoms.
Brand PL; Rijcken B; Schouten JP; Koëter GH; Weiss ST; Postma DS
Am Rev Respir Dis; 1992 Aug; 146(2):396-401. PubMed ID: 1489130
[TBL] [Abstract][Full Text] [Related]
7. Long-term variability of bronchial responsiveness to histamine in a random population sample of adults.
Rijcken B; Schouten JP; Weiss ST; Rosner B; De Vries K; Van der Lende R
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):944-9. PubMed ID: 8214948
[TBL] [Abstract][Full Text] [Related]
8. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: the Normative Aging Study.
O'Connor GT; Sparrow D; Weiss ST
Am J Respir Crit Care Med; 1995 Jul; 152(1):87-92. PubMed ID: 7599868
[TBL] [Abstract][Full Text] [Related]
9. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group.
Tashkin DP; Altose MD; Bleecker ER; Connett JE; Kanner RE; Lee WW; Wise R
Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):301-10. PubMed ID: 1736734
[TBL] [Abstract][Full Text] [Related]
10. The association of airways responsiveness to respiratory symptom prevalence and to pulmonary function in a random population sample.
Rijcken B; Schouten JP; Weiss ST; Speizer FE; van der Lende R
Bull Eur Physiopathol Respir; 1987; 23(4):391-4. PubMed ID: 3690025
[TBL] [Abstract][Full Text] [Related]
11. The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function. The Normative Aging Study.
Parker DR; O'Connor GT; Sparrow D; Segal MR; Weiss ST
Am Rev Respir Dis; 1990 Mar; 141(3):589-94. PubMed ID: 2178525
[TBL] [Abstract][Full Text] [Related]
12. Smoking and airway hyperresponsiveness especially in the presence of blood eosinophilia increase the risk to develop respiratory symptoms: a 25-year follow-up study in the general adult population.
Jansen DF; Schouten JP; Vonk JM; Rijcken B; Timens W; Kraan J; Weiss ST; Postma DS
Am J Respir Crit Care Med; 1999 Jul; 160(1):259-64. PubMed ID: 10390409
[TBL] [Abstract][Full Text] [Related]
13. Does bronchial hyperresponsiveness precede or follow airway obstruction in asthma or COPD?
van Schayck CP; Dompeling E; Molema J; Folgering H; van Grunsven PM; van Weel C
Neth J Med; 1994 Oct; 45(4):145-53. PubMed ID: 7808576
[TBL] [Abstract][Full Text] [Related]
14. Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function.
Paoletti P; Carrozzi L; Viegi G; Modena P; Ballerin L; Di Pede F; Grado L; Baldacci S; Pedreschi M; Vellutini M
Am J Respir Crit Care Med; 1995 Jun; 151(6):1770-7. PubMed ID: 7767519
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study.
Grol MH; Gerritsen J; Vonk JM; Schouten JP; Koëter GH; Rijcken B; Postma DS
Am J Respir Crit Care Med; 1999 Dec; 160(6):1830-7. PubMed ID: 10588593
[TBL] [Abstract][Full Text] [Related]
16. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study.
Hospers JJ; Postma DS; Rijcken B; Weiss ST; Schouten JP
Lancet; 2000 Oct; 356(9238):1313-7. PubMed ID: 11073020
[TBL] [Abstract][Full Text] [Related]
17. The association between baseline lung function and bronchial responsiveness to methacholine.
Wassmer G; Jörres RA; Heinrich J; Wjst M; Reitmeir P; Wichmann HE
Eur J Med Res; 1997 Feb; 2(2):47-54. PubMed ID: 9085014
[TBL] [Abstract][Full Text] [Related]
18. Markers of impaired growth of pulmonary function in children and adolescents.
Ulrik CS; Backer V
Am J Respir Crit Care Med; 1999 Jul; 160(1):40-4. PubMed ID: 10390377
[TBL] [Abstract][Full Text] [Related]
19. The influence of increased bronchial responsiveness, atopy, and serum IgE on decline in FEV1. A longitudinal study in the elderly.
Tracey M; Villar A; Dow L; Coggon D; Lampe FC; Holgate ST
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):656-62. PubMed ID: 7881652
[TBL] [Abstract][Full Text] [Related]
20. Methacholine responsiveness, smoking, and atopy as risk factors for accelerated FEV1 decline in male working populations.
Frew AJ; Kennedy SM; Chan-Yeung M
Am Rev Respir Dis; 1992 Oct; 146(4):878-83. PubMed ID: 1416413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
